Salivary gland infection market dynamics are complex and influenced by multiple factors that determine occurrence of the disease, diagnose and treatment. Frequently, salivary gland inflammation and swelling results from bacterial or viral infections. Increasing global prevalence is the principal driver of salivary gland infection treatment market growth. Poor oral hygiene, dehydration, and a greater incidence of viral infections contribute to this increase.
Market dynamics are largely shaped by the diagnostic landscape. Diagnostic techniques for salivary gland infections have continued to evolve as healthcare providers seek early detection and quick intervention. Advanced imaging technologies such as ultrasound and sialography have taken over the market leading to increased accuracy in diagnosis at an appropriate time. This is attributed to the need for specific facts on which proper treatments can be based.
Market dynamics include a number of treatment options for salivary gland infections. For instance, antibiotics may be prescribed in case of bacterial infection whereas antiviral medications may be necessary for treating viral infection. Sometimes patients require surgical interventions when they encounter severe cases such as removal of obstructions or drainage of abscesses. The product range includes various pharmaceuticals used for distinct purposes in salivary glands’ infection therapy while their rivalry shapes up general tendencies within this sphere.
Moreover, regulatory environment greatly shapes market dynamics in terms of drug approval and commercialization regarding agents associated with saliva ducts inflammations (Saluja et al., 2008). This has resulted in strict regulations aimed at ensuring safety, efficacy as well as development and introduction into the market new products (Mabar et al., 2015). In order to maintain patient safety and reach better outcomes regulatory bodies demand highest quality standards hence companies operating within this sector must comply with them thereby enhancing stability and predictability across these spaces.
On another note, economic landscape and healthcare infrastructure variations across different regions also influence the market dynamics of salivary gland infections (Grolleman et al., 2015). This is because there is a high level of diagnosis in developed economies with well-established health care systems and access to state-of-the-art treatments (Grolleman et al., 2015). Conversely, developing regions experience low rates of awareness and accessibility as well as affordability of diagnostics and therapeutic options. This also contributes to altering market dynamics due to different healthcare disparities and various economic conditions between such areas.
Furthermore, technological advancements together with research activities also impact on the market dynamics of salivary gland infections (Bhattacharya et al., 2018). Researchers are still putting an effort to identify new therapeutic targets for these diseases, diagnostic biomarkers and innovative treatment methods (Bhattacharya et al., 2015). The emergence of breakthroughs in research could potentially change the face of this market by bringing about more effective interventions that are specifically targeted at certain cohorts. These moves are pushed by academic collaboration with industry players alongside relevant healthcare institutions in fostering product innovation which will eventually influence the growth trajectory of this sector.
Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.
Increasing prevalence of various salivary gland infections, changing disease patterns, and environmental changes are major drivers for the market growth. Rising funding for R&D and clinical trials are leading to improved product development is another key factor for market growth. Improved hygiene practices, growing awareness about self-care and advanced diagnosis and treatment options are important driving forces for the market.
Study objectives of salivary gland infection market:
FIGURE 1 SALIVARY GLAND INFECTION MARKET SHARE BY END USER, 2016 (%)
Sources: National Center for Biotechnology Information, U.S. Food and Drug Administration, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation
Intended Audience:
Research Methodology:
Sources: National Center for Biotechnology Information, U.S. Food and Drug Administration, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation
On the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.
On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.
On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
Key Companies in the market of Salivary Gland Infection Market include
The report for Global Salivary Gland Infection Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)